Clinical and Life Sciences · 25 September 2026 to 25 September 2026 · 1 headlines · STAT
STAT Plus: Kyverna’s cell therapy shows lasting autoimmune benefit
Kyverna's cell therapy has demonstrated durable benefit for autoimmune disease patients.
Kyverna's cell therapy has demonstrated durable benefit for autoimmune disease patients.